Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
about
FOXA1 modulates EAF2 regulation of AR transcriptional activity, cell proliferation, and migration in prostate cancer cells.Effects of ELL-associated factor 2 on ultraviolet radiation-induced cataract formation in micePhysical and Functional Interactions between ELL2 and RB in the Suppression of Prostate Cancer Cell Proliferation, Migration, and Invasion.Cell Type-Specific and Inducible PTEN Gene Silencing by a Tetracycline Transcriptional Activator-Regulated Short Hairpin RNA.Regulation of tumor suppressor EAF2 polyubiquitination by ELL1 and SIAH2 in prostate cancer cellsEZH2 promotes metabolic reprogramming in glioblastomas through epigenetic repression of EAF2-HIF1α signaling.EAF2 regulates DNA repair through Ku70/Ku80 in the prostate.A single-copy Sleeping Beauty transposon mutagenesis screen identifies new PTEN-cooperating tumor suppressor genes.Regulation of RNA polymerase II-mediated transcriptional elongation: Implications in human disease.Expression and prognostic significance of ELL-associated factor 2 in human prostate cancer.Combined Loss of EAF2 and p53 Induces Prostate Carcinogenesis in Male Mice.Conditional deletion of ELL2 induces murine prostate intraepithelial neoplasia.EAF2 and p53 Co-Regulate STAT3 Activation in Prostate Cancer.Advances in prostate cancer research models: From transgenic mice to tumor xenografting models.
P2860
Q35582347-B068573D-1D75-4031-94D1-D12CE67ECE03Q36225022-8FA6CA37-8F1E-4D87-8709-48FDA16B07DBQ36272250-B13B5494-2E1C-40EF-8542-506BB81EE7D9Q36356741-CBF16D6B-62F8-4141-BD07-953C42ED8155Q37301786-30355613-47E8-401B-B63E-8E1C6BC271EEQ37564360-B70ED4C8-2D38-4E03-944E-891E73152CC1Q37746393-FEEF26F9-4088-4ECB-A8A3-EEABA461D9A3Q38893862-6E4D92C5-3F6F-4C8B-879E-9D49FF9A4489Q38912988-15630B59-C60C-4717-A527-7FC94121AACAQ42673080-43B529F7-DFF9-4734-B2BB-DA9FA3F82060Q47657085-818F65E3-D924-41AA-829E-6461E4D642D7Q47701028-B5A7CD73-7F80-4C2F-B545-6D8654CC6043Q52666493-41D044C8-603B-41EF-9FE1-B7DBFEA9CC28Q55237889-A425F019-15D2-4297-8EE8-8BEE57BB0556
P2860
Concomitant loss of EAF2/U19 and Pten synergistically promotes prostate carcinogenesis in the mouse model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@ast
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@en
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@nl
type
label
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@ast
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@en
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@nl
prefLabel
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@ast
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@en
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@nl
P2093
P2860
P356
P1433
P1476
Concomitant loss of EAF2/U19 a ...... inogenesis in the mouse model.
@en
P2093
J B Nelson
K J O'Malley
L E Pascal
L H Rigatti
S Isharwal
P2860
P2888
P304
P356
10.1038/ONC.2013.190
P407
P577
2013-05-27T00:00:00Z
P5875
P6179
1007903716